A study to assess the effect of patient related factors on warfarin dosing.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- cardiovascular disease patients recieving warfarin therapy
- Registration Number
- CTRI/2015/12/006455
- Lead Sponsor
- Ramakanth GSH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Patients of either sex in age group between 18 to 65 years on warfarin therapy with INR between 2 to 3.5 and with stable total warfarin maintenance dose for three consecutive months will be included for the study.
Exclusion Criteria
Patients with INR outside the range of 2 to 3.5 and non-compliant to warfarin therapy and study procedure will be excluded from the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of oneâ??week vitamin K intake on total weekly warfarin doseTimepoint: 1 week
- Secondary Outcome Measures
Name Time Method Evaluation of data collected on age, gender and tobacco &/or alcohol consumption on total weekly warfarin doseTimepoint: 1 week